FDA Requires Lower Ambien Doses

The Food and Drug Administration is requiring makers of Ambien and similar sleeping pills to lower the dosage of their drugs, based on studies suggesting patients face a higher risk of injury due to morning drowsiness. The agency said Thursday that new research shows that the drugs remain in the bloodstream at levels high enough to interfere with alertness and coordination, which increases the risk of car accidents. Regulators are ordering drug manufacturers to cut the dose of the...Full Story
Commenting on this article is closed.